338 related articles for article (PubMed ID: 15620648)
1. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
Abbott DW; Wilkins A; Asara JM; Cantley LC
Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
[TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory diseases: is ubiquitinated NEMO at the hub?
Burns KA; Martinon F
Curr Biol; 2004 Dec; 14(24):R1040-2. PubMed ID: 15620634
[TBL] [Abstract][Full Text] [Related]
4. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
[TBL] [Abstract][Full Text] [Related]
5. MEKK4 sequesters RIP2 to dictate NOD2 signal specificity.
Clark NM; Marinis JM; Cobb BA; Abbott DW
Curr Biol; 2008 Sep; 18(18):1402-8. PubMed ID: 18775659
[TBL] [Abstract][Full Text] [Related]
6. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
7. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
8. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
[TBL] [Abstract][Full Text] [Related]
9. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.
Homer CR; Kabi A; Marina-García N; Sreekumar A; Nesvizhskii AI; Nickerson KP; Chinnaiyan AM; Nuñez G; McDonald C
J Biol Chem; 2012 Jul; 287(30):25565-76. PubMed ID: 22665475
[TBL] [Abstract][Full Text] [Related]
10. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.
Goncharov T; Hedayati S; Mulvihill MM; Izrael-Tomasevic A; Zobel K; Jeet S; Fedorova AV; Eidenschenk C; deVoss J; Yu K; Shaw AS; Kirkpatrick DS; Fairbrother WJ; Deshayes K; Vucic D
Mol Cell; 2018 Feb; 69(4):551-565.e7. PubMed ID: 29452636
[TBL] [Abstract][Full Text] [Related]
11. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
[TBL] [Abstract][Full Text] [Related]
12. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
13. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways.
Chen CM; Gong Y; Zhang M; Chen JJ
J Biol Chem; 2004 Jun; 279(24):25876-82. PubMed ID: 15075345
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.
Tigno-Aranjuez JT; Asara JM; Abbott DW
Genes Dev; 2010 Dec; 24(23):2666-77. PubMed ID: 21123652
[TBL] [Abstract][Full Text] [Related]
16. Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis.
Yang S; Wang B; Humphries F; Jackson R; Healy ME; Bergin R; Aviello G; Hall B; McNamara D; Darby T; Quinlan A; Shanahan F; Melgar S; Fallon PG; Moynagh PN
Nat Immunol; 2013 Sep; 14(9):927-36. PubMed ID: 23892723
[TBL] [Abstract][Full Text] [Related]
17. A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways.
Rosenstiel P; Huse K; Till A; Hampe J; Hellmig S; Sina C; Billmann S; von Kampen O; Waetzig GH; Platzer M; Seegert D; Schreiber S
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3280-5. PubMed ID: 16492792
[TBL] [Abstract][Full Text] [Related]
18. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
Yan R; Liu Z
Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
[TBL] [Abstract][Full Text] [Related]
20. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
